Even with rough markets last week, there were some exchange traded funds (ETFs) that ended on a positive note. Some were the narrowly-focused health care ETFs, HealthShares Autoimmune-Inflammation (HHA) and HealthShares Metabolic-Endocrine (HHM), which were up 7.7% and 7.1% respectively, according to Kevin Baker for TheStreet.com.
SPDR S&P Biotech (XBI) was another ETF that ended the week well. It closed up 5.7%. As we mentioned before, the health care sector, which can include biotechs, is generally a safe place to be when the market is all over the place. People will always get sick and need medicine that biotechs work to create, so they tend not to follow market trends. So analysts recommend not to let market volatility drive you crazy, says Adam Feuerstein for TheStreet.com. Keep an eye on the trends, and have your exit strategy in place.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.